A cluster-randomized effectiveness trial of a physician-pharmacist collaborative model to improve blood pressure control

Circulation: Cardiovascular Quality and Outcomes

Volumn 3, Issue 4, 2010, Pages 418-423

  Carter, Barry L ^a,b,e   Clarke, William ^b   Ardery, Gail ^a   Weber, Cynthia A ^a   James, Paul A ^b   Weg, Mark Vander ^c,e   Chrischilles, Elizabeth A ^b   Vaughn, Thomas ^d   Egan, Brent M ^f,g  

^a Department of Pharmacy Practice and Science ^*  (United States)

^b UNIVERSITY OF IOWA   (United States)

^c Department of Epidemiology   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e Department of Epidemiology ^*  (United States)

^f UNIVERSITY OF IOWA COLLEGE OF NURSING   (United States)

^g MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Blood pressure; Clinical trial; Hypertension; Pharmacists

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL PHARMACY; CLINICAL TRIAL; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVALUATION; FEMALE; GEOGRAPHY; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HOSPITAL DEPARTMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACIST; PHYSICIAN; PHYSICIAN PHARMACIST COLLABORATIVE MODEL; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

BLOOD PRESSURE MONITORING, AMBULATORY; CLUSTER ANALYSIS; COMPARATIVE EFFECTIVENESS RESEARCH; COOPERATIVE BEHAVIOR; FOLLOW-UP STUDIES; GUIDELINE ADHERENCE; HUMANS; MODELS, THEORETICAL; PATIENT CARE TEAM; PHARMACISTS; PHYSICIANS, PRIMARY CARE; POPULATION GROUPS; PROSPECTIVE STUDIES; RESEARCH DESIGN; UNITED STATES;

EID: 77957868087     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.109.908038     Document Type: Article

References (28)

1. Milchak JL, Carter BL, James PA, Ardery G. Measuring adherence to practice guidelines for the management of hypertension: An evaluation of the literature. Hypertension. 2004;44:602-608.
2. Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Kader B, Moskowitz MA. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339:1957-1963.
3. Oliveria SA, Lapuerta P, McCarthy BD, L'Italien GJ, Berlowitz DR, Asch SM. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med. 2002;162:413-420.
4. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345:479-486.
5. Grumbach K, Bodenheimer T. Can health care teams improve primary care practice? JAMA. 2004;291:1246-1251.
6. Rosenthal TC. Advancing medical homes: Evidence-based literature review to inform health policy. Available at: Http://www.ahec.buffalo.edu/reports/ medical-home-evidence-review07.pdf. Accessed June 2, 2010.
7. Carter BL, Bergus GR, Dawson JD, Farris KB, Doucette WR, Chrischilles EA, Hartz AJ. A cluster randomized trial to evaluate physician/ pharmacist collaboration to improve blood pressure control. J Clin Hypertens. 2008;10:260-271.
8. Carter BL, Ardery G, Dawson JD, James PA, Bergus GR, Doucette WR, Chrischilles EA, Franciscus CL, Xu Y. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009;169: 1996-2002.
9. Carter BL, Rogers M, Daly J, Zheng S, James PA. The potency of team-based care interventions for hypertension: A meta-analysis. Arch Intern Med. 2009;169:1748-1755.
10. Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, Oxman AD, Moher D. Improving the reporting of pragmatic trials: An extension of the CONSORT statement. BMJ. 2008;337:a2390.
11. Armitage CJ, Conner M. Efficacy of the theory of planned behaviour: A meta-analytic review. Brit J Soc Psychol. 2001;40:471-499.
12. Dickerson LM, Kraus C, Kuo GM, Weber CA, Bazaldua OV, Tovar JM, Hume AL, Ives TJ, Gums JG, Carter BL. Formation of a primary care pharmacist practice-based research network. Am J Health Syst Pharm. 2007;64:2044-2049.
13. Billups SJ, Okano G, Malone D, Carter BL, Valuck R, Barnette DJ, Sintek CD. Assessing the structure and process for providing pharmaceutical care in Veterans Affairs medical centers. Am J Health Syst Pharm. 2000;57:29-39.
14. Malone DC, Carter BL, Billups SJ, Valuck RJ, Barnette DJ, Sintek CD, Okano GJ, Ellis S, Covey D, Mason B, Jue S, Carmichael J, Guthrie K, Sloboda L, Dombrowski R, Geraets DR, Amato MG. An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans: The IMPROVE study. Impact of Managed Pharmaceutical Care Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy. 2000;20: 1149-1158.
15. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289:2560-2572.
16. Major outcomes in high-risk hypertensive patients randomized to angiotensin- converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981-2997.
17. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: Blood pressure measurement in humans: A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005;45: 142-161.
18. Von Muenster SJ, Carter BL, Weber CA, Ernst ME, Milchak JL, Steffensmeier JJ, Xu Y. Description of pharmacist interventions during physician-pharmacist co-management of hypertension. Pharm World Sci. 2008;30:128-135.
19. Rose AJ, Berlowitz DR, Orner MB, Kressin NR. Understanding uncontrolled hypertension: Is it the patient or the provider? J Clin Hypertens. 2007;9:937-943.
20. Kressin NR, Wang F, Long J, Bokhour BG, Orner MB, Rothendler J, Clark C, Reddy S, Kozak W, Kroupa LP, Berlowitz DR. Hypertensive patients' race, health beliefs, process of care, and medication adherence. J Gen Intern Med. 2007;22:768-774.
21. Milchak JL, Carter BL, Ardery G, Black HR, Bakris GL, Jones DW, Kreiter CD. Development of explicit criteria to measure adherence to hypertension guidelines. J Hum Hypertens. 2006;20:426-433.
22. Milchak JL, Carter BL, Ardery G, Dawson JD, Harmston M, Franciscus CL. Physician adherence to blood pressure guidelines and its effect on seniors. Pharmacotherapy. 2008;28:843-851.
23. Ardery G, Carter BL, Milchak JL, Bergus GR, Dawson JD, James PA, Franciscus C, Kim Y. Explicit and implicit evaluation of physician adherence to hypertension guidelines. J Clin Hypertens. 2007;9:113-119.
24. Aizen I. Behavioral interventions based on the theory of planned behavior. Available at: Http://people.umass.edu/aizen/tpb.html. Accessed June 2, 2010.
25. Grimshaw JM, Zwarenstein M, Tetroe JM, Godin G, Graham ID, Lemyre L, Eccles MP, Johnston M, Francis JJ, Hux J, O'Rourke K, Legare F, Presseau J. Looking inside the black box: A theory-based process evaluation alongside a randomised controlled trial of printed educational materials (the Ontario printed educational message, OPEM) to improve referral and prescribing practices in primary care in Ontario, Canada. Implement Sci. 2007;2:38.
26. Thompson CA. Pharmacists' CPT codes become permanent: Next step is to set valuation for each code. Am J Health Syst Pharm. 2007;64: 2410-2412.
27. Donner A, Klar N. Statistical considerations in the design and analysis of community intervention trials. J Clin Epidemiol. 1996;49:435-439.
28. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913.